Clinical evaluation of a new halcinonide-antifungal combination.
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D002179:Candidiasis, Cutaneous / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D007464:Clioquinol / Q000008:administration & dosage / Q000627:therapeutic use; D003872:Dermatitis / Q000188:drug therapy*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D006854:Hydrocortisone; D007223:Infant; D008297:Male; D008875:Middle Aged; D009355:Neomycin / Q000008:administration & dosage* / Q000627:therapeutic use; D009761:Nystatin / Q000008:administration & dosage* / Q000627:therapeutic use; D011282:Pregnenediones / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D005938:Glucocorticoids; D011282:Pregnenediones; D009761:Nystatin; D007464:Clioquinol; D009355:Neomycin; D006854:Hydrocortisone